Thrombolysis treatment for acute ischaemic stroke in a patient on treatment with dabigatran

Thrombosis and Haemostasis

Volumn 106, Issue 1, 2011, Pages 178-179

  Matute, María Consuelo ^a   Guillán, Marta ^a   García Caldentey, Juan ^a   Buisán, Javier ^a   Aparicio, María ^a   Masjuan, Jaime ^a   de Leciñana, María Alonso ^a  

^a HOSPITAL RAMÓN Y CAJAL   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

DABIGATRAN; TISSUE PLASMINOGEN ACTIVATOR;

AGED; APHASIA; BRAIN ISCHEMIA; CAROTID ATHEROSCLEROSIS; CASE REPORT; ECHOCARDIOGRAPHY; ECHOGRAPHY; FEMALE; FIBRINOLYTIC THERAPY; HEART LEFT VENTRICLE HYPERTROPHY; HEMIPLEGIA; HOMONYMOUS HEMIANOPIA; HUMAN; PRIORITY JOURNAL; REVIEW; VEIN THROMBOSIS;

AGED; ANTITHROMBINS; APHASIA; BENZIMIDAZOLES; BETA-ALANINE; CAROTID ARTERY DISEASES; FEMALE; FRACTURE FIXATION; HEMIPLEGIA; HEMORRHAGE; HUMANS; ISCHEMIA; POSTOPERATIVE COMPLICATIONS; PRACTICE GUIDELINES AS TOPIC; PROSTHESIS FAILURE; RISK; STROKE; THROMBOLYTIC THERAPY; THROMBOSIS;

EID: 79960101903     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH11-01-0042     Document Type: Review

References (7)

1. Adams HP Jr, del Zoppo G, Alberts MJ, et al; American Heart Association; American Stroke Association Stroke Council; Clinical Cardiology Council; Cardiovascular Radiology and Intervention Council; Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups. Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: the American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists. Stroke 2007; 38: 1655-1711.
2. Connolly SJ, Ezekowitz MD, Yusuf S, et al.; RE-LY Steering Committee and Investigators. Dabigatran versus warfarin in patients with atrial fribrillation. N Engl J Med 2009; 361: 1139-1151.
3. Dempfle CE, Hennerici MG. Dabigatran and stroke thrombolysis. Cerebrovasc Dis 2010; 30: 203-205.
4. van Ryn J, Stangier J, Haertter S, et al. Dabigatran etexilate - a novel, reversible, oral direct thrombin inhibitor: interpretation of coagulation assays and reversal of anticoagulant activity. Thromb Haemost 2010; 103: 1116-1127.
5. Lindahl TL, Baghaei F, Fagerberg Blixter I, et al.; and from the expert group on coagulation of the External Quality Assurance in Laboratory Medicine in Sweden. Effects of the oral, direct thrombin inhibitor dabigatran on five common coagulation assays. Thromb Haemost 2011; 105: 371-378.
6. Boehringer Ingelheim Canada: Pradrax™ Product Monograph, rev. Burlington, Boehringer Ingelheim Canada, 2009.
7. De Smedt A, De Raedt S, Nieboer K, et al. Intravenous Thrombolysis with Recombinant Tissue Plasminogen Activator in a Stroke Patient Treated with Dabigatran. Cerebrovasc Dis 2010; 30: 533-534.